Stanford-StartX Fund Backed Nirmidas Bioteh, Raises $2 Million for Diagnostic Research Tools

"With pGOLD technology, afflictions such as cancer, auto-immune disorders, cardiovascular disease, and diabetes can be detected at earlier stages and with better accuracy by creating non-invasive, point-of-care testing. Early detection could significantly change the nature and cost of patient care."